PNC Financial Services Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-40
Closed -$16K 4276
2017
Q3
$16K Hold
40
﹤0.01% 3501
2017
Q2
$24K Sell
40
-33
-45% -$19.3K ﹤0.01% 3263
2017
Q1
$45K Hold
73
﹤0.01% 2935
2016
Q4
$15K Sell
73
-67
-48% -$15.2K ﹤0.01% 3351
2016
Q3
$38K Hold
140
﹤0.01% 2946
2016
Q2
$42K Buy
140
+20
+17% +$7.03K ﹤0.01% 2921
2016
Q1
$51K Hold
120
﹤0.01% 2825
2015
Q4
$60K Buy
120
+43
+56% +$31.1K ﹤0.01% 2736
2015
Q3
$91K Buy
77
+33
+75% +$50.5K ﹤0.01% 2586
2015
Q2
$78K Hold
44
﹤0.01% 2784
2015
Q1
$52K Buy
44
+4
+10% +$4.74K ﹤0.01% 3032
2014
Q4
$39K Buy
+40
New +$40.1K ﹤0.01% 2897

Other funds holding VYNT

PNC Financial Services Group's VYNT Position: Q4 2017 in Review

PNC Financial Services Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2017, closing a stake of 40 shares — an estimated $16K sold.

PNC Financial Services Group first reported a position in VYNT in Q4 2014 and held it in 12 quarters. The position peaked at $91K in Q3 2015. 25 funds tracked by Wall St. Rank hold VYNT as of Q4 2017.

  • PNC Financial Services Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 40 Vyant Bio, Inc. Common Stock shares in Q4 2017, an estimated $16K.
  • PNC Financial Services Group first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
  • PNC Financial Services Group's Vyant Bio, Inc. Common Stock position peaked at $91K in Q3 2015.
  • 25 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2017.

Based on PNC Financial Services Group's 13F filing for Q4 2017, filed 9 Feb 2018.